In today’s episode, I interview Dr. Dale Bredesen, an internationally respected researcher into the causes of neurodegenerative diseases. He’s a New York Times bestselling author with three books: The End of Alzheimer’s, The End of Alzheimer’s Programme and The First Survivors of Alzheimer’s. Dr. Bredesen is currently the Chief Science Officer (CSO) of Apollo Health and a professor at UCLA.  He was the founding CEO of the Buck Institute for Age Research in Marin County, CA.  

In many respects Dr. Bredesen’s the reason I’m producing these podcasts, having been the person who first put me on the road to my own recovery. Before Dr. Bredesen’s clinical studies, it was assumed by the entire medical community that there was nothing that could be done to stop the progression of Alzheimer’s. His book, The End of Alzheimer’s, demonstrated that there was a way to slow the onset of dementia and even reverse it. 

Over 900,000 Americans have died from COVID-19, but of those currently living, 45 million will die from Alzheimer’s. Thus far, despite tens of billions of dollars spent by Big Pharma, there has been no cure and nothing on the horizon. Even these failed drug trials had only sought to slow the progression of the disease.  

Results of a clinical trial of the Bredesen Protocol were released in October 2021.  They show that cognition stabilized or improved for 84% of the dataset which consisted of individuals with subjective cognitive impairment, mild cognitive impairment, and early Alzheimer’s disease. Several went from not knowing what year or month it was to normal brain function using the Bredesen Protocol.  

Dr. Bredesen’s work represents a revolution in the way we think of Alzheimer’s, not as a disease with a single cause, but more as a pathology resulting from a variety of bodily insults associated with aging.